The Coca-Cola Company has recalled some Sprite, Fanta, and Diet Coke batches. The beverage manufacturer takes about 2,000 cases of the said drinks off the market shelves.
As per NBC News, the U.S. Food and Drug Administration (FDA) announced the recall through a filing. While this event was only publicized this week, the food and drug authority said the call back of Coca-Cola’s Sprite, Diet Coke, and Fanta actually started last month.
Reason for the Recall and Affected Products
The FDA revealed that Coca-Cola’s latest beverage recall involves 1,557 cases of Sprite in 12-ounce cans with the Best By date of 07/29/24, 417 cases of Diet Coke (Best By 01/29/24), and 14 cases of Fanta Orange (Best By 07/29/24). The particular batches affected by the recall were said to have been manufactured by United Packers, which is located in Alabama.
The recalled drinks were distributed in three states: Florida, Alabama, and Mississippi. The main reason for the recall is the potential presence of foreign material in the canned drinks. Coca-Cola said no other products besides the three mentioned brands and batches are affected.
Update on the Recall
In a statement that Coca-Cola’s representative shared with PEOPLE, the company has completed all the recall activities in the affected market. Then again, the “foreign material” type found in the soft drinks was not specified in the reports.
Meanwhile, Today reported that this is not the first time Coca-Cola issued a recall for the same reason of possible “foreign material” contamination. In 2021, the beverage maker recalled several variants of its Minute Maid juice products because some foreign metal objects were suspected to have tainted the drinks. At that time, about 7,000 cases of the voluntarily recalled juice were classified by the FDA as Class II recall.
Photo by: Senad Palic/Unsplash


9 Tips for Avoiding Tax Season Cyber Scams
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained 



